Yu CJ Chey
Josh is an early-career researcher in the Jenkins Cancer and Immune Signalling Laboratory at the South Australian immunoGENomics Cancer Institute (SAiGENCI). His research surrounds the role of innate immunity in pancreatic cancer, aiming to identify and validate novel biomarkers and therapeutic targets for the disease. https://researchers.adelaide.edu.au/profile/yuchinnjoshua.chey
Abstracts this author is presenting: